APA

Paulson K. G., Voillet V., McAfee M. S., Hunter D. S., Wagener F. D., Perdicchio M., Valente W. J., Koelle S. J., Church C. D., Vandeven N., Thomas H., Colunga A. G., Iyer J. G., Yee C., Kulikauskas R., Koelle D. M., Pierce R. H., Bielas J. H., Greenberg P. D., Bhatia S., Gottardo R., Nghiem P. & Chapuis A. G. (20190115). Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. : Nature communications.

Chicago

Paulson K G, Voillet V, McAfee M S, Hunter D S, Wagener F D, Perdicchio M, Valente W J, Koelle S J, Church C D, Vandeven N, Thomas H, Colunga A G, Iyer J G, Yee C, Kulikauskas R, Koelle D M, Pierce R H, Bielas J H, Greenberg P D, Bhatia S, Gottardo R, Nghiem P and Chapuis A G. 20190115. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. : Nature communications.

Harvard

Paulson K. G., Voillet V., McAfee M. S., Hunter D. S., Wagener F. D., Perdicchio M., Valente W. J., Koelle S. J., Church C. D., Vandeven N., Thomas H., Colunga A. G., Iyer J. G., Yee C., Kulikauskas R., Koelle D. M., Pierce R. H., Bielas J. H., Greenberg P. D., Bhatia S., Gottardo R., Nghiem P. and Chapuis A. G. (20190115). Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. : Nature communications.

MLA

Paulson K G, Voillet V, McAfee M S, Hunter D S, Wagener F D, Perdicchio M, Valente W J, Koelle S J, Church C D, Vandeven N, Thomas H, Colunga A G, Iyer J G, Yee C, Kulikauskas R, Koelle D M, Pierce R H, Bielas J H, Greenberg P D, Bhatia S, Gottardo R, Nghiem P and Chapuis A G. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. : Nature communications. 20190115.